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A B S T R A C T
Detecting reactive oxygen species (ROS) that play a critical role as redox modulators and signalling molecules in biological systems currently requires invasive
methods such as ROS -specific indicators for imaging and quantification. We developed a non-invasive, real-time, label-free imaging technique for assessing the level
of ROS in live cells and thawed cryopreserved tissues that is compatible with in-vivo imaging. The technique is based on autofluorescence multispectral imaging
(AFMI) carried out in an adapted fluorescence microscope with an expanded number of spectral channels spanning specific excitation (365 nm–495 nm) and emission
(420 nm–700 nm) wavelength ranges. We established a strong quantitative correlation between the spectral information obtained from AFMI and the level of ROS
obtained from CellROX staining. The results were obtained in several cell types (HeLa, PANC1 and mesenchymal stem cells) and in live kidney tissue. Additioanly,two
spectral regimes were considered: with and without UV excitation (wavelengths > 400 nm); the latter being suitable for UV-sensitive systems such as the eye. Data
were analyzed by linear regression combined with an optimization method of swarm intelligence. This allowed the calibration of AFMI signals to the level of ROS
with excellent correlation (R = 0.84, p = 0.00) in the entire spectral range and very good correlation (R = 0.78, p = 0.00) in the limited, UV-free spectral range. We
also developed a strong classifier which allowed us to distinguish moderate and high levels of ROS in these two regimes (AUC = 0.91 in the entire spectral range and
AUC = 0.78 for UV-free imaging). These results indicate that ROS in cells and tissues can be imaged non-invasively, which opens the way to future clinical
applications in conditions where reactive oxygen species are known to contribute to progressive disease such as in ophthalmology, diabetes, kidney disease, cancer
and neurodegenerative diseases.
1. Introduction
Accurate reactive oxygen species (ROS) quantification and char-
acterization plays an important role in the investigation of metabolism
[1,2], inflammatory responses [3–5], the pathogenesis of the disease
[6,7], treatment monitoring [8–11] and potentially provides prognostic
information [12–15]. Currently, standard ROS measurement uses var-
ious molecular indicators such as dichlorofluorescein, a fluorescent
probe that reacts intracellularly with peroxidase, or CellROX, a
fluorogenic probe for measuring oxidative stress in live cells and tissue
[16–18]. However, due to challenges with administration and potential
toxicity molecular ROS probes may not be suitable for in-vivo use
[16,19]. To overcome these limitations an imaging technique which can
measure ROS levels directly, without any staining, in clinical and re-
search environments, is highly desirable.
In this study, we employed autofluorescence multispectral imaging
(AFMI) [20,21] to non-invasively characterize ROS levels. The
autofluorescence emission in cells or tissues originates from en-
dogenous fluorophores including collagen, elastin, tryptophan and re-
duced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H), fla-
vins [21–23]. The autofluorescence emission of some of these, most
notably NAD(P)H, depends on its oxidation state. NAD(P)H is fluor-
escent wheras NAD+ is not, and the relative balance of these two de-
pends on the level of ROS [24,25]. This allows the status of cellular,
mitochondrial or cytosolic ROS to be non-invasively evaluated and
monitored [26].
AFMI is a new technology that uses an adapted fluorescence mi-
croscope which provides light excitation in several narrow (+/- 5 nm)
wavelength ranges and collects the native fluorescence emission of the
sample, also at defined wavelength ranges [20,21]. Each excitation
/emission wavelength band combination forms a specific spectral
channel and we used a number of such channels (here 18) to collect
detailed spectral image information from cells and tissue. Following
AFMI, the slide-mounted cells and tissue were stained using CellROX
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and imaged again to establish the reference ROS values. These were
matched with the corresponding AFMI data in each individual cell or
tissue section separately.
Non-invasive evaluation of ROS in real-time was achieved by cali-
brating the cellular AFMI data against the ROS data from CellROX, on a
single-cell level. This calibration was based on selected color features
extracted from the single-cell AFMI images and the corresponding
CellROX images. The data sets were then used to develop classifiers,
with a threshold based on the median of CellROX values, allowing the
non-invasive determination of whether the ROS level in cells and tissues
was moderate or elevated. We have also developed a UV-free version of
the AFMI vs ROS (CellROX) calibration and a related UV-free classifier
where the UV channels with excitation wavelengths of less than 400 nm
were avoided; this is relevant for UV-sensitive applications such as in
reproductive medicine and ophthalmology. Taken together these results
represent a novel methodology that allows objective, non-invasively
determination of ROS levels related to oxidative metabolism or redox
dysregulation in cells and tissues from multispectral images using au-
tomated technology.
2. Methods
2.1. Sample preparation and ROS stimulation
In this study we investigated neoplastic cells (HeLa and PANC1),
human bone marrow derived mesenchymal stem cells (MSC) (isolated
as described previously [27,28]) and cryopreserved whole kidney tissue
sections obtained from 13 week old Balb/c mice, which were exposed to
either air or smoke in utero, as we have previously demonstrated that
they express increased levels of ROS [29]. Full details of cell culture and
ethics approvals are included in Supplementary Material note 1. To
stimulate ROS accumulation, cells were exposed to 30μM menadione
(Sigma) in the culture media for 0, 30, 60, 90 and 120 min. For ima-
ging, cells were plated onto 35mm ibiTreat coverslip bottomed dishes
with 500μm grids (Ibidi).
2.2. Autofluorescence multispectral imaging (AFMI)
The (AFMI) system used in this study is based on an adapted IX83
Olympus microscope as previously reported [22,30,31]. It provides
narrow excitation wavelength ranges (±5nm) from high power LEDs
and several filter cubes to produce defined spectral regions, which span
the excitation (340 nm–510 nm) and emission (420 nm–650 nm) wa-
velength ranges. In total, 18 distinct spectral channels (Nch=18) are
available and the samples are imaged in all these channels (examples of
spectral channles are shown in Fig. 1(c,d)). These channels cover the
spectrum of several fluorophores notably NAD(P)H and flavins, whose
concentrations depend on the cellular redox conditions. The spectral
details of the channels are shown in Supplementary Table 1. The system
also takes differential contrast microscopy (DIC) images. A CCD camera
with a high quantum efficiency (Andor IXON 885 EMCCD, Andor
Technology Ltd., UK) was used to acquire the fluorescence images in
the spectral channels. The images were captured at 40× magnification
(an example of MSC DIC image is shown in Fig. 1(a)).We imaged in the
order of 100 cells from each cell type and about 70 tissue regions from
the kidney tissue (~500um2). The channel images were prepared for
subsequent quantitative analysis. Image preparation is a multistep
procedure that minimizes sources of errors such as Poisson’s noise, dead
or saturated pixels, background fluorescence and the illumination
curvature [32]. These artifacts were treated as previously reported
[21,33].
2.3. CellROX and nuclear staining
Following AFMI imaging, cell/tissue samples were stained with
CellROX Deep Red (Thermo Fisher). CellROX Deep Red is a cell-
permeant dye which stains the cytoplasm. This probe detects super-
oxide anion and hydroxyl radicals [34]. To obtain the reference ROS
values, CellROX was applied to cells/tissue on the slides for 30 min as
per manufacturer’s instructions, followed by imaging on an Olympus
FV3000 confocal microscope for hMSC cell lines and kidney tissue, or a
Leica FLUOTAR340 for the cancer cell lines (an example CellROX image
is shown in Fig. 1(b)). Nuclear counter-staining was performed with
Hoechst 3(3342 (NucBlue, Thermo Fisher).
2.4. Image analysis
The cells and tissue regions were segmented manually, on the basis
of their DIC images taken during AFMI imaging, and by using confocal
CellROX images. Further, the average channel or CellROX values in the
segmented cells or tissue regions were calculated. Autofluorescence
feature vectors containing these average channel values (18 channels)
and all ratio of average channel values (18 × 17 ratios) for each cell
were obtained. The CellROX images were, similarly, segmented and the
average cellular value of the CellROX signal (providing the reference
ROS value) was found for each cell/tissue sector. Finally, the corre-
sponding cells and tissue regions were identified in the AFMI and
CellROX images. The ROS reference values were then appended to the
324-dimensional autofluorescence feature vectors (AFMI vectors) ob-
tained from AFMI for all cells or tissue regions.
2.5. Calibration - relating AFMI to ROS reference values from CellROX
The aim of system calibration is to identify a small subset of AFMI
features whose optimized linear combination is approximately pro-
portional to the CellROX ROS values, for all individual cells, or tissue
sectors. This is achieved by swarm intelligence [35] combined with the
regression model [36,37]. The optimized linear combination of AFMI
features (a “spectral variable”) represents the cellular CellROX data in
the “best” way, by numerically minimizing the sum of squared errors
for all cells. The error is the difference between the average cellular
CellROX values and the average values of that spectral variable for a
particular cell or tissue region (see Supplementary Material note 2).
2.6. Non-invasive assessment of ROS by classification of AFMI data
To distinguish cells with high ROS levels from cells with moderate
ROS levels, we developed the AFMI-based classification method. In this
method cells and tissue regions were assigned to high or moderate ROS
groups using the median cellular value of CellROX signal as a
threshold.The cluster analysis was first applied to separate cell groups
and further classifiers were employed to predict the pre-defined cell
labels [38].
2.7. UV-free ROS calibration and classifiers
To develop the calibration and classifiers for UV-sensitive applica-
tions, the same analysis described in Sections 2.5 and 2.6 was con-
ducted without AFMI channels with excitation at the UV range (ex-
citation wavelengths from 400nm to 495nm).
3. Results and discussion
Linear regression combined with the method of swarm intelligence
detected an approximately linear dependence between an optimized
autofluorescence feature (spectral variable) and ROS levels determined
by CellROX staining. This spectral variable was different for each
sample and we did not find a significant similarity between spectral
variables associated with different cell lines and tissue. The goodness of
the calibration curves was statistically evaluated based on coefficient of
determination (R) and associated p-values (Supplementary note 3 and
supplementary table 2), which were found to range from 0.76
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(p = 0.00) to 0.92(p = 0.00) for the full excitation spectrum, and 0.74
(p = 0.00) to 0.87 (p = 0.00) (Fig. 2) for the UV-free spectrum
(Supplementary Fig. 1). The lowest intracellular ROS concentration
detectable by AFMI for HeLa/PANC1/MSC/kidney tissue is approxi-
mately 0.55 /0.50 /0.90 /1.2 of the average native fluorophore con-
centration, which is in the micromolar range [39–41].
We further developed classifiers to distinguish cells with a high level
of ROS from those with a moderate level of ROS [38,42]. The same data
and classification models developed here were used to evaluate the
level of ROS in 3 different cell lines and kidney tissue. The classifiers
were constructed using discrimination analysis to separate the cells
with high-level ROS from cells with a moderate level [20](further de-
tails in supplementary note 4). Fig. 3 and Supplementary Figure 2 show
the clusters formed by cells with high and moderate ROS level obtained
using the entire excitation spectrum and UV-free excitation spectrum,
respectively.
The receiver operating characteristic (ROC) graph was obtained to
determine the performance of this classifier for each sample as shown in
Fig. 4 [43]. Overall, the classifiers for different samples showed similar
performance with average accuracies of 84% and 79% and AUCs of
0.91 and 0.87 for the entire excitation spectrum and UV-free excitation
spectrum, respectively (see Supplementary Table 2 for further related
statistics). The sensitivity of AFMI corresponding to true positive rate of
the classifiers, averaged over all samples in Fig. 4 were found to be 89%
and 83% for the entire excitation spectrum and for the UV-free ex-
citation spectrum, respectively.
In this study, we demonstrate the use of a non-invasive auto-fluor-
escence multispectral imaging technique for the quantitative analysis of
ROS-related spectral signatures of cells and tissue preserving spatial
information. This technology is capable of measuring the value of ROS
with high accuracy and also classifying the cells into moderate and high
levels of ROS. It does not perturb biology as it does not require cell
labeling or any other interference, and it has the ability to assess
cryopreserved and fixed tissue, reflecting the redox state of cells after
fixation. We tested neoplastic cells (HeLa and PANC1), human bone
marrow derived mesenchymal stem cells (MSC) and cryopreserved
whole kidney tissue; however, this technique can be used for a range of
different cell and tissue types.
Oxidative stress is a hallmark of multiple chronic diseases associated
with older age such as diabetes, cardiovascular, renal, pulmonary,
neurological and skeletal muscle disorders [44]. In addition, it is known
to play a pivotal role in disease onset and development [45], such as the
development and progression of diabetes complications both micro-
vascular and macrovascular [46,47]. As such, our novel technique has
great clinical application not only in disease detection but also in
studying the underlying mechanisms and role of oxidative stress in
disease onset and progression.
AFMI requires a fairly simple adaptation of a fluorescence micro-
scope using low power LEDs (see Supplementary Material Table 1)
[20]; this allows the extraction of informative spectral maps of cells and
tissues which contain details on the biochemical composition of the
sample which correlates with the level of ROS. This simplicity and low
cost make AFMI easily translatable to the clinical setting. The im-
mediate application of this study would be monitoring ROS state in
embryology, reproductive medicine and ophthalmology.
4. Conclusions
In conclusion, we found that cellular autofluorescence imaging with
spectral selectivity non-invasively determines the level of ROS in cells
Fig. 1. (a) An example of MSC DIC image. (b) an example CellROX image. (c),(d) examples of spectral image channels 2 and 13, respectively.
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Fig. 2. Regression curve used to calibrate the AFMI system to measure the states of the ROS using full spectrum. (a) HeLa (R = 0.86), (b) PANC1 (R = 0.83), (c) MSC
(R = 0.76) (d) kidney tissue (R = 0.92).
Fig. 3. Cell/tissue classification into high and mod-
erate ROS. To visualize the data distribution for each
group, an ellipse was defined for each cluster which
represents the standard deviation of the data points.
(a) HeLa cells (IoU = 8.3%), (b) PANC1 cells
(IoU = 5.1%), (c) MSCs (IoU = 22%) (d) kidney
tissue (IoU = 0%). Results shown here used the full-
spectral range.
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and tissues. We developed calibration curves and classifiers for auto-
matic measurement. AFMI provides a promising measurement tool for
ROS which can be translated to future clinical and research applica-
tions.
Declaration of competing interest
Authors declare no conflict of interest.
Acknowledgment
We acknowledge the support of the Australian Research Council
CE140100003, and DP170101863, and National Health and Medical
Research Council APP1144619. We thank Hui Chen (University of
Technology Sydney) and Professor Stan Gronthos (South Australia
Health and Medical Research Institute) for supplying the cells and an-
imal tissue for the study.
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.redox.2020.101561.
References
[1] L.A. del Rio, ROS and RNS in plant physiology: an overview, J. Exp. Bot. 66 (10)
(2015) 2827–2837.
[2] V.J. Thannickal, B.L. Fanburg, M. Physiology, Reactive oxygen species in cell sig-
naling, Am. J. Physiol. Lung Cell Mol. Physiol. 279 (6) (2000) L1005–L1028.
[3] T. Finkel, Signal transduction by reactive oxygen species, J. Cell Biol. 194 (1)
(2011) 7–15.
[4] K. Abe, et al., In vivo imaging of reactive oxygen species in mouse brain by using
[3H] hydromethidine as a potential radical trapping radiotracer, 34 (12) (2014)
1907–1913.
[5] L. Wu, et al., Reaction-based fluorescent probes for the detection and imaging of
reactive oxygen, nitrogen, and sulfur species, 52 (9) (2019) 2582–2597.
[6] W.J.P.r. Droge, Free radicals in the physiological control of cell function, 82 (1)
(2002) 47–95.
[7] U.S. Srinivas, et al., ROS and the DNA Damage Response in Cancer, (2018), p.
101084.
[8] B. Kalyanaraman, et al., Measuring reactive oxygen and nitrogen species with
fluorescent probes: challenges and limitations, 52 (1) (2012) 1–6.
[9] B. D'Autréaux, M.B. Toledano, ROS as signalling molecules: mechanisms that gen-
erate specificity in ROS homeostasis, Nat. Rev. Mol. Cell Biol. 8 (10) (2007) 813.
[10] R. Datta, et al., Fluorescence Lifetime Imaging of Endogenous Biomarker of
Oxidative Stress vol. 5, (2015), p. 9848.
[11] A.J. Payne, et al., Antioxidant drug therapy approaches for neuroprotection in
chronic diseases of the retina, 15 (2) (2014) 1865–1886.
[12] C. Sun, et al., A reactive oxygen species scoring system predicts cisplatin sensitivity
and prognosis in ovarian cancer patients, 19 (1) (2019) 1061.
[13] P. Cheng, et al., Near-infrared fluorescence probes to detect reactive oxygen species
for keloid diagnosis, 9 (30) (2018) 6340–6347.
[14] J. Huang, et al., Molecular Optical Imaging Probes for Early Diagnosis of Drug-
Induced Acute Kidney Injury, (2019), pp. 1–11.
[15] Y. Luo, et al., Measurement of reactive oxygen species by fluorescent probes in
pancreatic cancer cells, Pancreatic Cancer, Springer, 2019, pp. 207–219.
[16] M.C. Prunty, et al., In vivo imaging of retinal oxidative stress using a reactive
oxygen species–activated fluorescent probe, 56 (10) (2015) 5862–5870.
[17] R. Sharma, et al., Methods to measure reactive oxygen species (ROS) and total
antioxidant capacity (TAC) in the reproductive system, Oxidative Stress in Human
Reproduction, Springer, 2017, pp. 17–46.
[18] J. Woolley, J. Stanicka, T.G. Cotter, Recent advances in reactive oxygen species
measurement in biological systems, Trends. Biochem. Sci. 38 (11) (2013) 556–565.
[19] C. Xie, et al., Nanoparticle regrowth enhances photoacoustic signals of semi-
conducting macromolecular probe for in vivo imaging, 29 (44) (2017) 1703693.
[20] A. Habibalahi, et al., Optimized autofluorescence spectral signature for non-in-
vasive diagnostics of ocular surface squamous neoplasia, OSSN) 7 (2019)
141343–141351.
[21] A. Habibalahi, et al., Novel Automated Non Invasive Detection of Ocular Surface
Squamous Neoplasia Using Multispectral Autofluorescence Imaging, (2019).
[22] M.E. Gosnell, et al., Functional hyperspectral imaging captures subtle details of cell
metabolism in olfactory neurosphere cells, disease-specific models of neurodegen-
erative disorders, Biochim. Biophys. Acta Mol. Cell Res. 1863 (1) (2016) 56–63 %@
Fig. 4. ROC curve for the accuracy of discrimination
between cells and tissues with different level of ROS
(a) HeLa cells (AUC = 0.92/0.84 and
Sensitivity = 91%/81% for full spectrum/UV- free
spectrum), (b) PANC1 cells (AUC = 0.92/0.89,
Sensitivity = 90%/87%), (c) MSCs (AUC = 0.82/
0.80, Sensitivity = 75%/70%) (d) CKD tissue
(AUC = 1.00/0.98, Sensitivity = 100%/95%).
A. Habibalahi, et al. Redox Biology 34 (2020) 101561
5
0167-4889.
[23] M.J. Bertoldo, et al., NAD+ repletion rescues female fertility during, Reproductive
Aging 30 (6) (2020) 1670–1681 e7.
[24] P. Bondza-Kibangou, et al., Modifications of cellular autofluorescence emission
spectra under oxidative stress induced by 1 α, 25dihydroxyvitamin D3 and its
analog EB1089, 3 (4) (2004) 383–391.
[25] P. Bondza‐Kibangou, et al., Microspectrofluorometry of autofluorescence emission
from human leukemic living cells under oxidative stress, 93 (5) (2001) 273–280.
[26] G.A. Wagnieres, W.M. Star, B.C. Wilson, In vivo fluorescence spectroscopy and
imaging for oncological applications, Photochem. Photobiol. 68 (5) (1998) 603–632
%@ 1751-1097.
[27] S. Isenmann, et al., TWIST family of basic helix-loop-helix transcription factors
mediate human mesenchymal stem cell growth and commitment, Stem Cell. 27 (10)
(2009) 2457–2468.
[28] S. Shi, S. Gronthos, Perivascular niche of postnatal mesenchymal stem cells in
human bone marrow and dental pulp, J. Bone Miner. Res. 18 (4) (2003) 696–704.
[29] S. Sukjamnong, et al., MitoQ supplementation prevent long-term impact of ma-
ternal smoking on renal development, oxidative stress and mitochondrial density in
male mice offspring, 8 (1) (2018) 6631.
[30] M.E. Gosnell, et al., Quantitative non-invasive cell characterisation and dis-
crimination based on multispectral autofluorescence features, Sci. Rep. 6 (2016)
23453 %@ 2045-2322.
[31] A.U. Rehman, et al., Fluorescence quenching of free and bound NADH in HeLa cells
determined by hyperspectral imaging and unmixing of cell autofluorescence,
Biomed. Optic Express 8 (3) (2017) 1488–1498 %@ 2156-7085.
[32] M. Gosnel, Unlocking the Potential of Spectral Imaging for the Characterization of
Cells and Stem Cells Population, Macquarei University, Thesis, 2013.
[33] S.B. Mahbub, et al., Statistically strong label-free quantitative identification of na-
tive fluorophores in a biological sample, Sci. Rep. 7 (1) (2017) 15792 %@ 2045-
2322.
[34] E.C.C. Celeghini, et al., Efficiency of CellROX Deep Red® and CellROX Orange®
Fluorescent Probes in Identifying Reactive Oxygen Species in Sperm Samples from
High and Low Fertility Bulls, (2019), pp. 1–7.
[35] Panigrahi, B.K., Y. Shi, and M.-H. Lim, Handbook of Swarm Intelligence: Concepts,
Principles and Applications. Vol. vol. 8 %@ 364217390X. 2011: Springer Science &
Business Media.
[36] A. Habibalahi, M.J.M.S. Safizadeh, Technology, Pulsed eddy current and ultrasonic
data fusion applied to stress measurement, 25 (5) (2014) 055601.
[37] A. Habibalahi, M.S. Safizadeh, Monitoring, Forward to residual stress measurement by
using pulsed eddy current technique, Insight - Non-Destructive Testing and Condition
Monitoring 55 (9) (2013) 492–497.
[38] V. Vapnik, The Nature of Statistical Learning Theory, Springer science & business
media, 2013.
[39] A. Shrivastava, V.B. Gupta, Methods for the determination of limit of detection and
limit of quantitation of the analytical methods, Chronicles Young Sci. 2 (1)
(2011) 21.
[40] K. Yamada, et al., The simultaneous measurement of nicotinamide adenine dinu-
cleotide and related compounds by liquid chromatography/electrospray ionization
tandem mass spectrometry, 352 (2) (2006) 282–285.
[41] D. Williamson, P. Lund, H.J.B.J. Krebs, The redox state of free nicotinamide-ade-
nine dinucleotide in the cytoplasm and mitochondria of rat liver, 103 (2) (1967)
514.
[42] A. Habibalahi, et al., Improving pulse eddy current and ultrasonic testing stress
measurement accuracy using neural network data fusion, 9 (4) (2015) 514–521.
[43] D.J. Hand, R.J. Till, A simple generalisation of the area under the ROC curve for
multiple class classification problems, Mach. Learn. 45 (2) (2001) 171–186 %@
0885-6125.
[44] C. Cabello-Verrugio, et al., Oxidative Stress in Disease and Aging: Mechanisms and
Therapies, (2016) 2016.
[45] A. Umeno, V. Biju, Y.J.F.r.r. Yoshida, In vivo ROS production and use of oxidative
stress-derived biomarkers to detect the onset of diseases such as Alzheimer's dis-
ease, Parkinson’s disease, and diabetes 51 (4) (2017) 413–427.
[46] F. Giacco, M.J.C.r. Brownlee, Oxidative stress and diabetic complications, 107 (9)
(2010) 1058–1070.
[47] R.A. Kowluru, P.-S. Chan, Oxidative Stress and Diabetic Retinopathy, Exp. Diabetes
Res. 2007 (2007) .
A. Habibalahi, et al. Redox Biology 34 (2020) 101561
6
